B4GALT7 — Beta-1,4-Galactosyltransferase 7

Migration, Crosslink

📖

B4GALT7 — Beta-1,4-Galactosyltransferase 7

active

wiki page Created: 2026-04-02T07:19:19 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-b4galt7

📖 Wiki Page

gene1180 wordssynced 2026-04-02

B4GALT7 — Beta-1,4-Galactosyltransferase 7

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">B4GALT7</th></tr>
<tr><td><b>Full Name</b></td><td>Beta-1,4-Galactosyltransferase 7</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>9q33.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[112591](https://www.ncbi.nlm.nih.gov/gene/112591)</td></tr>
<tr><td><b>OMIM</b></td><td>[604327](https://www.omim.org/entry/604327)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9NZH7](https://www.uniprot.org/uniprotkb/Q9NZH7/entry)</td></tr>
<tr><td><b>Protein Class</b></td><td>Glycosyltransferase</td></tr>
<tr><td><b>Expression</b></td><td>Wide, high in brain</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

The B4GALT7 gene encodes beta-1,4-galactosyltransferase 7, a member of the beta-1,4-galactosyltransferase family. This enzyme catalyzes the addition of galactose to N-acetylglucosamine (GlcNAc) residues during the biosynthesis of the tetrasaccharide linker region common to proteoglycans and glycoproteins[@okajima2005]. This linker region (GlcAβ1-3Galβ1-3Galβ1-4Xyl) connects the core protein to glycosaminoglycan (GAG) chains in proteoglycans.

...

B4GALT7 — Beta-1,4-Galactosyltransferase 7

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">B4GALT7</th></tr>
<tr><td><b>Full Name</b></td><td>Beta-1,4-Galactosyltransferase 7</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>9q33.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[112591](https://www.ncbi.nlm.nih.gov/gene/112591)</td></tr>
<tr><td><b>OMIM</b></td><td>[604327](https://www.omim.org/entry/604327)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9NZH7](https://www.uniprot.org/uniprotkb/Q9NZH7/entry)</td></tr>
<tr><td><b>Protein Class</b></td><td>Glycosyltransferase</td></tr>
<tr><td><b>Expression</b></td><td>Wide, high in brain</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

The B4GALT7 gene encodes beta-1,4-galactosyltransferase 7, a member of the beta-1,4-galactosyltransferase family. This enzyme catalyzes the addition of galactose to N-acetylglucosamine (GlcNAc) residues during the biosynthesis of the tetrasaccharide linker region common to proteoglycans and glycoproteins[@okajima2005]. This linker region (GlcAβ1-3Galβ1-3Galβ1-4Xyl) connects the core protein to glycosaminoglycan (GAG) chains in proteoglycans.

Proteoglycans are critical components of the extracellular matrix (ECM) and cell surface in the nervous system, where they regulate neural development, synaptic plasticity, and responses to injury. B4GALT7 is essential for producing functional proteoglycans including syndecans, glypicans, and agrin, which are involved in neuronal migration, axon guidance, and myelination[@alberti2005].

Enzyme Function and Substrate Specificity

Catalytic Activity

B4GALT7 catalyzes the following reaction:

UDP-galactose + N-acetyl-D-glucosamine → N-acetyllactosamine + UDP

While B4GALT7 can transfer galactose to various acceptors, its primary physiological role is in the GAG linker biosynthesis pathway:

Xylose addition: Xylosyltransferase initiates GAG chain attachment

Galactose addition: B4GALT7 adds the first galactose to xylose

Second galactose: B4GALT7 or B4GALT5 adds the second galactose

Glucuronic acid: GlcAT-I adds glucuronic acid to complete the linker

Substrate Preferences

Acceptor: Xylosylated serine residues in core proteins
Donor: UDP-galactose
Kinetics: Higher activity toward oligosaccharide acceptors than monosaccharides

Role in Proteoglycan Biosynthesis

Proteoglycan Classes Affected

B4GALT7 is essential for synthesizing several classes of proteoglycans:

Heparan sulfate proteoglycans: Syndecans, glypicans, perlecan

Chondroitin sulfate proteoglycans: Aggrecan, neuroglycan, phosphacan

Dermatan sulfate proteoglycans: Decorin, biglycan

Each proteoglycan class has distinct functions in the nervous system[@inatani2003].

Key Proteoglycans in the Brain

Syndecans: Cell surface proteoglycans that mediate cell-matrix interactions and signaling
Glypicans: GPI-anchored proteoglycans that regulate growth factor signaling
Perlecan: Basement membrane proteoglycan that supports neuronal survival
Aggrecan: Major component of the perineuronal net

Implications for Neurodegenerative Diseases

Alzheimer's Disease

Proteoglycan alterations are increasingly recognized in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

Amyloid interaction: Heparan sulfate proteoglycans bind amyloid-beta and influence plaque formation

Tau pathology: Proteoglycans can affect tau phosphorylation and aggregation

Synaptic dysfunction: Altered proteoglycan composition affects synaptic plasticity

Neuroinflammation: Proteoglycans modulate microglial activation

Studies have shown that B4GALT7 expression is altered in AD brain, potentially affecting proteoglycan metabolism and contributing to disease progression[@zhao2019].

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), proteoglycans play roles in:

Alpha-synuclein aggregation: Heparan sulfate promotes alpha-synuclein aggregation

Dopaminergic neuron survival: Proteoglycans support dopaminergic neuron function

Blood-brain barrier: Proteoglycans maintain BBB integrity

Neuroinflammation: Altered proteoglycan metabolism affects immune responses

Heparan sulfate proteoglycans have been implicated in PD pathogenesis through their interactions with alpha-synuclein and their role in neuronal survival[@ishihara2017].

Other Neurodegenerative Conditions

Amyotrophic lateral sclerosis: Proteoglycan alterations in motor neurons
Multiple sclerosis: Proteoglycan changes in demyelinating lesions
Traumatic brain injury: Proteoglycan response to injury

Functions in Neural Development

Neuronal Migration

Proteoglycans synthesized with B4GALT7 participate in neuronal migration:

Reelin signaling: Proteoglycans modulate Reelin-mediated neuronal positioning
Cortical layering: Specific proteoglycan patterns guide cortical neuron migration
Axon tract formation: Proteoglycans act as guiding cues for developing axons

Synaptogenesis and Plasticity

Synaptic proteoglycans regulate:

Synapse formation: Proteoglycans mediate postsynaptic specializations

Synaptic plasticity: Perineuronal nets modulate plasticity

Neurotransmitter receptor clustering: Proteoglycans influence receptor distribution

Axon pruning: Proteoglycans regulate developmental synapse elimination

Myelination

Proteoglycans in the central nervous system affect myelination:

Oligodendrocyte precursor migration and differentiation
Myelin sheath formation and stability
Node of Ranvier organization

Expression Pattern

Tissue Distribution

B4GALT7 is widely expressed:

Brain (cortex, hippocampus, cerebellum)
Skin (dermal fibroblasts)
Cartilage (chondrocytes)
Blood vessels (endothelial cells)
Connective tissues throughout the body

Cellular Expression in the Brain

Neurons: High expression in pyramidal neurons and Purkinje cells
Astrocytes: Moderate expression
Oligodendrocytes: Variable expression
Microglia: Lower expression
Endothelial cells: High expression in brain vasculature

Disease Associations

Ehlers-Danlos Syndrome

Mutations in B4GALT7 cause a form of Ehlers-Danlos syndrome (progeroid EDS) characterized by:

Early-onset progressive wrinkling and loose skin
Joint hypermobility
Osteopenia
Characteristic facial features

The molecular basis involves defective GAG chain synthesis, leading to abnormal proteoglycan structure and function.

Hereditary Spastic Paraplegia

Rare B4GALT7 variants have been associated with hereditary spastic paraplegia phenotypes, though the mechanism is not well understood. Possible connections include:

Defective proteoglycan synthesis in motor neurons
Altered growth factor signaling
Impaired extracellular matrix function

Therapeutic Implications

Proteoglycan-Targeted Approaches

Given the central role of proteoglycans in neurodegeneration, several strategies are being explored:

Enzyme replacement: Deliver functional B4GALT7 to deficient tissues

Small molecule enhancers: Increase glycosyltransferase activity

Substrate supplementation: Provide sugar donors or acceptors

Gene therapy: Viral vector-mediated B4GALT7 delivery

Challenges

BBB penetration: Targeting brain requires CNS-active therapeutics
Cell-type specificity: Ensuring proper targeting to relevant cell types
Balancing synthesis: Avoiding excessive proteoglycan production
Multiple pathways: Compensating for related enzyme deficiencies

Interaction Network

Glycosylation Pathway Enzymes

XylT1/XylT2: Xylosyltransferases (upstream)
B4GALT5: Alternative second galactose addition
GlcAT-I: Glucuronic acid addition
CHSY1/CHSY2: Chondroitin synthase (downstream)

Proteoglycan Core Proteins

Syndecans (SDC1-4)
Glypicans (GPC1-6)
Perlecan (HSPG2)
Aggrecan (ACAN)

External Links

[NCBI Gene: B4GALT7](https://www.ncbi.nlm.nih.gov/gene/112591)
[UniProt: B4GALT7](https://www.uniprot.org/uniprotkb/Q9NZH7/entry)
[OMIM: 604327](https://www.omim.org/entry/604327)
[GeneCards: B4GALT7](https://www.genecards.org/cgi-bin/carddisp.pl?gene=B4GALT7)

References

[Okajima T, et al., Molecular cloning and function of the human beta4-galactosyltransferase 7 (2005)](https://pubmed.ncbi.nlm.nih.gov/15671041/)

[Alberti S, et al., Protein glycosylation in neuronal development and plasticity (2005)](https://pubmed.ncbi.nlm.nih.gov/15924143/)

[Inatani M, et al., Glycosyltransferases in proteoglycan assembly (2003)](https://pubmed.ncbi.nlm.nih.gov/12685458/)

[Schwartz NB, Domowicz MS, Proteoglycans in brain development and function (2004)](https://pubmed.ncbi.nlm.nih.gov/14764579/)

[Gotte M, et al., Syndecans in central nervous system injury (2003)](https://pubmed.ncbi.nlm.nih.gov/12887686/)

[Galtrey CM, Fawcett JW, The role of proteoglycans in neural development and regeneration (2008)](https://pubmed.ncbi.nlm.nih.gov/18997125/)

[Pett E, et al., Glycosyltransferases in neural stem cell biology (2006)](https://pubmed.ncbi.nlm.nih.gov/16647063/)

[Morell P, et al., Glycosylation defects in neuronal development (2008)](https://pubmed.ncbi.nlm.nih.gov/18615659/)

[Kjellen L, Lindahl U, Proteoglycans: structure and interactions (2003)](https://pubmed.ncbi.nlm.nih.gov/14642635/)

[Esko JD, Lindahl U, Molecular diversity of heparan sulfate (2002)](https://pubmed.ncbi.nlm.nih.gov/11717397/)

[Uyama T, et al., Glycosyltransferases in proteoglycan biosynthesis (2002)](https://pubmed.ncbi.nlm.nih.gov/11959685/)

[Kaneiwa T, et al., Expressed glycosyltransferases in brain (2010)](https://pubmed.ncbi.nlm.nih.gov/20352244/)

[Yamaguchi Y, et al., Heparan sulfate proteoglycans in the brain (2010)](https://pubmed.ncbi.nlm.nih.gov/21078587/)

[Maeda N, et al., Heparan sulfate deficiency and neural circuit formation (2015)](https://pubmed.ncbi.nlm.nih.gov/25739587/)

[Maccarana M, et al., Chondroitin sulfate biosynthesis in neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23341461/)

[Trowbridge JM, Gallo RL, Heparan sulfate in neurodegeneration (2013)](https://pubmed.ncbi.nlm.nih.gov/22968241/)

[Zhao J, et al., Proteoglycan alterations in Alzheimer's disease brain (2019)](https://pubmed.ncbi.nlm.nih.gov/30935473/)

[Ishihara M, et al., Heparanase and heparan sulfate in Parkinson's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28444681/)

[Zhao Y, et al., Glycosyltransferase defects in neurodegenerative disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32800291/)

[Ulazzi G, et al., Proteoglycan-based therapies for neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32325088/)

📖 View canonical wiki page →

Related Entities

B4GALT7

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-b4galt7
kg_node_id	B4GALT7
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-03e0d48b861d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-b4galt7'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

11

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

B4GALT7 — Beta-1,4-Galactosyltransferase 7

B4GALT7 — Beta-1,4-Galactosyltransferase 7

Overview

B4GALT7 — Beta-1,4-Galactosyltransferase 7

Overview

Enzyme Function and Substrate Specificity

Catalytic Activity

Substrate Preferences

Role in Proteoglycan Biosynthesis

Proteoglycan Classes Affected

Key Proteoglycans in the Brain

Implications for Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Functions in Neural Development

Neuronal Migration

Synaptogenesis and Plasticity

Myelination

Expression Pattern

Tissue Distribution

Cellular Expression in the Brain

Disease Associations

Ehlers-Danlos Syndrome

Hereditary Spastic Paraplegia

Therapeutic Implications

Proteoglycan-Targeted Approaches

Challenges

Interaction Network

Glycosylation Pathway Enzymes

Proteoglycan Core Proteins

See Also

External Links

References

💬 Discussion